215 related articles for article (PubMed ID: 37015826)
1. Relapsing Encephalomyelitis After COVID-19 Infection and Vaccination: From the National MS Society Case Conference Proceedings.
Roy S; Barreras P; Pardo CA; Graves JS; Zamvil SS; Newsome SD
Neurol Neuroimmunol Neuroinflamm; 2023 May; 10(3):. PubMed ID: 37015826
[TBL] [Abstract][Full Text] [Related]
2. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
3. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
[TBL] [Abstract][Full Text] [Related]
4. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis and Optic Neuritis After COVID-19 Vaccination and Relapsing Optic Neuritis After COVID-19 Infection.
Huang KI; Cheng CK; Peng PH
J Neuroophthalmol; 2024 Jun; 44(2):e219-e221. PubMed ID: 36857140
[No Abstract] [Full Text] [Related]
5. Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination.
Jain E; Donowitz JR; Aarons E; Marshall BC; Miller MP
Emerg Infect Dis; 2022 May; 28(5):990-993. PubMed ID: 35275051
[TBL] [Abstract][Full Text] [Related]
6. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination.
Vogrig A; Janes F; Gigli GL; Curcio F; Negro ID; D'Agostini S; Fabris M; Valente M
Clin Neurol Neurosurg; 2021 Sep; 208():106839. PubMed ID: 34325334
[TBL] [Abstract][Full Text] [Related]
7. Acute Disseminated Encephalomyelitis After SARS-CoV-2 Vaccination.
Ahmad HR; Timmermans VM; Dakakni T
Am J Case Rep; 2022 Jun; 23():e936574. PubMed ID: 35717556
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.
Becerril-Gaitan A; Vaca-Cartagena BF; Ferrigno AS; Mesa-Chavez F; Barrientos-Gutiérrez T; Tagliamento M; Lambertini M; Villarreal-Garza C
Eur J Cancer; 2022 Jan; 160():243-260. PubMed ID: 34794855
[TBL] [Abstract][Full Text] [Related]
9. New-Onset Acute Interstitial Nephritis Post-SARS-CoV-2 Infection and COVID-19 Vaccination: A Panoramic Review.
Wang Y; Yang L; Xu G
J Epidemiol Glob Health; 2023 Dec; 13(4):615-636. PubMed ID: 37870719
[TBL] [Abstract][Full Text] [Related]
10. Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection From the Canadian National Vaccine Safety Network.
Bettinger JA; Irvine MA; Shulha HP; Valiquette L; Muller MP; Vanderkooi OG; Kellner JD; Top KA; Sadarangani M; McGeer A; Isenor JE; Marty K; Soe P; De Serres G;
Clin Infect Dis; 2023 Mar; 76(6):1088-1102. PubMed ID: 36310514
[TBL] [Abstract][Full Text] [Related]
11. Case of Pilomatricoma After Coronavirus Disease 2019 Vaccination.
Nakazono M; Kawai M; Mizukami A; Kondoh A; Yamaoka H; Mabuchi T
Tokai J Exp Clin Med; 2023 Apr; 48(1):10-12. PubMed ID: 36999388
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review.
Afshar ZM; Barary M; Babazadeh A; Hosseinzadeh R; Alijanpour A; Miri SR; Sio TT; Sullman MJM; Carson-Chahhoud K; Langer F; Ebrahimpour S
Rev Med Virol; 2022 Jul; 32(4):e2327. PubMed ID: 35112763
[TBL] [Abstract][Full Text] [Related]
13. Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan.
Sato T; Kodama S; Kaneko K; Imai J; Katagiri H
Emerg Infect Dis; 2022 Jul; 28(7):1518-1520. PubMed ID: 35468049
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré Syndrome Associated with COVID-19 Vaccination.
Finsterer J; Scorza FA; Scorza CA
Emerg Infect Dis; 2022 May; 28(5):1079-1080. PubMed ID: 35447058
[No Abstract] [Full Text] [Related]
15. Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients.
Mohseni Afshar Z; Babazadeh A; Janbakhsh A; Afsharian M; Saleki K; Barary M; Ebrahimpour S
Rev Med Virol; 2022 Mar; 32(2):e2273. PubMed ID: 34197678
[TBL] [Abstract][Full Text] [Related]
16. Risk of Incident Thromboembolic and Ischemic Events After COVID-19 Vaccination Compared With SARS-CoV-2 Infection.
Lassen MCH; Modin D; Skaarup KG; Johansen ND; Claggett B; Solomon SD; Fralick M; Jensen JUS; Sivapalan P; Vaduganathan M; Pareek M; Schou M; Krause TG; Hviid A; Køber L; Torp-Pedersen C; Gislason G; Biering-Sørensen T
Circulation; 2023 Mar; 147(10):843-845. PubMed ID: 36877771
[No Abstract] [Full Text] [Related]
17. Seropositive rheumatoid arthritis after vaccination against SARS-CoV-2 infection.
Baimukhamedov C; Makhmudov S; Botabekova A
Int J Rheum Dis; 2021 Nov; 24(11):1440-1441. PubMed ID: 34585843
[No Abstract] [Full Text] [Related]
18. Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection.
Baimukhamedov C
Int J Rheum Dis; 2021 Sep; 24(9):1218-1220. PubMed ID: 34363344
[No Abstract] [Full Text] [Related]
19. De novo and relapsing glomerulonephritis after COVID-19 vaccination: how much do we know?
Chan ATP; Tang SCW
Nephrology (Carlton); 2022 Jan; 27(1):5-6. PubMed ID: 34933411
[No Abstract] [Full Text] [Related]
20. Severe Multisystem Inflammatory Symptoms in 2 Adults after Short Interval between COVID-19 and Subsequent Vaccination.
Jenny-Avital ER; Howe RA
Emerg Infect Dis; 2022 May; 28(5):1017-1020. PubMed ID: 35320702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
